Access cutting-edge chronic myelomonocytic leukemia treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Portland location
Access chronic myelomonocytic leukemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic myelomonocytic leukemia treatment provided free
Check if you qualify for this chronic myelomonocytic leukemia clinical trial in Portland, OR
No-Cost Study Care
Local to Portland
Convenient for OR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is an open-label, nonrandomized phase 2 trial to assess the efficacy of cobimetinib in RAS pathway activated CMML. All eligible patients will be treated daily with cobimetinib in 28-day cycles. Cobimetinib will be administered for three weeks followed by a one week break prior to the start of the following cycle. Patients will remain on study therapy until treatment discontinuation criteria is met.
Sponsor: University of Utah
Yes, this clinical trial (NCT04409639) has an active research site in Portland, OR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic myelomonocytic leukemia treatment options in Portland, OR, this clinical trial (NCT04409639) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic myelomonocytic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic myelomonocytic leukemia clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Portland — not just this study.
Browse Leukemia Trials in Portland →